Marginal treatment benefit in anaplastic thyroid cancer

Because anaplastic thyroid cancer is a rare malignancy with a high mortality rate, the benefit of multimodality treatment was evaluated.

[1]  Kathleen A Cronin,et al.  The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. , 2014, Cancer.

[2]  T. Pawlik,et al.  What are patients' expectations about the effects of chemotherapy for advanced cancer? , 2014, Journal of the American College of Surgeons.

[3]  Y. Nikiforov,et al.  American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[4]  T. Smith,et al.  Palliative communications: addressing chemotherapy in patients with advanced cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  N. Lee,et al.  Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Kunihiko Ito,et al.  Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[7]  R. Smallridge,et al.  Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. , 2011, Thyroid : official journal of the American Thyroid Association.

[8]  Thomas J. Smith,et al.  Explaining Marginal Benefits to Patients, When “Marginal” Means Additional but Not Necessarily Small , 2010, Clinical Cancer Research.

[9]  H. Prigerson,et al.  Influence of patients' preferences and treatment site on cancer patients' end‐of‐life care , 2010, Cancer.

[10]  J. Tward,et al.  Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results 1983–2002 , 2008, American journal of clinical oncology.

[11]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[12]  Tae Yong Kim,et al.  Prognostic factors for Korean patients with anaplastic thyroid carcinoma , 2007, Head & neck.

[13]  E. Kebebew,et al.  Anaplastic thyroid carcinoma , 2005, Cancer.

[14]  C. Earle,et al.  Trends in the aggressiveness of cancer care near the end of life. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Grimelius,et al.  Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery , 2002, British Journal of Cancer.

[16]  G. Thompson,et al.  Anaplastic thyroid carcinoma: a 50-year experience at a single institution. , 2001, Surgery.

[17]  J. Quivey,et al.  Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival , 2001, Cancer.

[18]  G. Lundell,et al.  Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma. Report on two protocols , 1994, Cancer.

[19]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[20]  N. Ordóñez,et al.  Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases , 1990, Cancer.

[21]  R. Leeper,et al.  Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy a new approach , 1983 .

[22]  Jae Ho Kim,et al.  Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy a new approach , 1982, Cancer.

[23]  M. Schlumberger.  Anaplastic thyroid carcinoma. , 2005, Head & neck.

[24]  C. Brocheriou.  [Anaplastic carcinoma of the thyroid]. , 1998, Archives d'anatomie et de cytologie pathologiques.